Sepsis is a major cause of mortality and morbidity for hospitalized patients around the world. Early intervention can reduce mortality and morbidity from severe sepsis, but signs and symptoms of sepsis are non-specific. Point-of-care lactate has proved to be an invaluable tool for some institutions in standardized...

Various guidelines and recommendations are available for the use of natriuretic peptides in the diagnosis of heart failure. As it is known that old age may lead to higher natriuretic peptide values in the absence of heart failure, it is relevant to decide whether to use age-dependent reference intervals for clinical...

Emergency departments (ED) are challenged by increasing patient visits, overcrowding and prolonged length of stay (LOS). The cause of these problems is multifactorial. Delays in the laboratory are often perceived as contributing to delays in care and increased LOS. Implementation of selected point-of-care tests in...

Postoperative cardiovascular event including myocardial infarction or heart failure is a major cause of morbidity after non-cardiac surgery. Preoperative evaluation including estimation of the probability of perioperative cardiac event and application of non-invasive testing or beta-blocker has been developed, but...

Point-of-care testing sites continue to increase in number due to the availability of easy-to-use devices that make it possible to provide test results very quickly relative to the central laboratory services. There is, however, mixed review regarding the accuracy and reliability of POCT results for patient care. It...

ROC curves are frequently used to show in a graphical way the connection/trade-off between clinical sensitivity and specificity for every possible cut-off for a test or a combination of tests. In addition the area under the ROC curve gives an idea about the benefit of using the test(s) in question.  ROC curves are...

As healthcare seeks to provide better care with fewer resources, Point-of-Care Testing steps in to move key diagnostic or screening tests to the patient’s bedside. The results can have a significant impact on a patient outcome and operational costs.

The following is a copy of an article from Nursing 2007, Fall 2007 Volume 37 Number 8 - Supplement: ED Insider, Pages 14 - 16 The D-dimer level is a measure of clot formation and lysis that results from the degradation of cross-linked fibrin. Widely used as an indicator for the presence of disseminated intravascular ...

The growing role of cardiac markers has been elucidated in patients with acute coronary syndrome, heart failure and other cardiovascular diseases. The markers can be cytosolic like heart-type fatty-acid-binding protein (H-FABP) and creatine kinase MB (CKMB), myofibrillary like troponin T (TnT) and cardio-endocrine...

When a new D-dimer method is to be implemented either as a substitute for a currently used D-dimer assay or as a supplement, maybe as a point-of-care assay, it is necessary to do a clinical comparison of the "old" assay versus the "new" assay. The major pitfalls in D-dimer comparisons are addressed in this paper.   ...